AskBio Inc. logo

AskBio Inc.

Pioneering science to create transformative molecular medicines.

526 employees · est. 2001 · United States

VS
AVROBIO logo

AVROBIO

Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring personalized gene therapy worldwide

16 employees · est. 2015 · Cambridge, United States

AskBio Inc. is the older company (2001 vs 2015); AskBio Inc. is the larger of the two.

Side-by-Side Comparison

AskBio Inc. AVROBIO
Founded
2001 older 2015
Headquarters
United States Cambridge, United States
Employees
526 larger 16
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health Care
Funding Stage
Grant Acquired
Total Funding
$241.09M $110.00M
Funding Rounds
4 7
Services
Development of Gene Therapies, Clinical Trial Management, AAV Gene Therapy Programs, Biotechnology Research Not tracked yet
Target Customers
Patients with Genetic Diseases, Medical Researchers, Biopharmaceutical Companies, Healthcare Providers Not tracked yet
Taxonomy
Gene Therapy, Molecular Medicine, AAV Technology, Rare Diseases, Neuromuscular Disorders, Central Nervous System Disorders, Cardiovascular Diseases, Metabolic Diseases, Congestive Heart Failure, Limb-Girdle Muscular Dystrophy, Parkinson's Disease, Pompe Disease, Pro10 Manufacturing Process, Capsid And Promoter Library, Biopharmaceutical Industry Gene Therapy, Lentiviral Gene Therapy, Clinical Stage, Plato Platform, Personalized Medicine, Genetic Disease, Hematopoietic Stem Cells, Gaucher Disease, Hunter Syndrome, Pompe Disease, Cambridge, Clinical Programs, Global Commercialization
Website
askbio.com avrobio.com
AskBio Inc. logo

About AskBio Inc.

AskBio Inc., a wholly-owned and independently operated subsidiary of Bayer AG, is making significant strides in the biotechnology sector. Established in 2001, the company is headquartered in the United States and is a leader in the development of transformative gene therapies aimed at addressing ser...

AVROBIO logo

About AVROBIO

AVROBIO is a United States-based, clinical-stage biotechnology company founded in 2015. With its headquarters in Cambridge, Mass., the firm is advancing the field of gene therapy with its proprietary plato® platform. Driven by the slogan, "Clinical-stage lentiviral gene therapy company, powered by...

We will tell you when either one moves

BounceWatch watches AskBio Inc. and AVROBIO for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at AskBio Inc. and AVROBIO — by email.

Frequently Asked Questions

AskBio Inc. — Pioneering science to create transformative molecular medicines.. AVROBIO — Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring personalized gene therapy worldwide. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
AskBio Inc. has raised $241.09M while AVROBIO has raised $110.00M.
AskBio Inc. and AVROBIO operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare AskBio Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at AskBio Inc. on 9 Jun 2026, and AVROBIO on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes